As part of Taiwan president Tsai Ing-wen's five-plus-two innovative industries initiative, Taiwan is looking to transform into a center of biotechnology and medical R&D in Asia and has budgeted NT$10.94 billion (about US$360 million) in 2017 for a biomedical...
The article requires paid subscription.
Subscribe Now